Previous studies demonstrated the involvement of CD36 in the progression of atherosclerosis, and also that deletion or blockage of the CD36-induced signalling pathway decreased the development of atherosclerotic lesions in mice [7,8]. This evidence concerns the gene CD36 and atherosclerosis.